| MR编号 | UK/H/6568/004 | ||||||
|---|---|---|---|---|---|---|---|
| 药品名称 | Abstral 400 microgram sublingual tablets | ||||||
| 活性成分 |
| ||||||
| 剂型 | Sublingual tablet | ||||||
| 上市许可持有人 | Head Of Regulatory Affairs ACTAVIS UK LIMITED WHIDDON VALLEY BARNSTAPLE EX32 8NS UNITED KINGDOM | ||||||
| 参考成员国 - 产品名称 | United Kingdom (GB) | ||||||
| 互认成员国 - 产品名称 | |||||||
| 许可日期 | 2019/05/14 | ||||||
| 最近更新日期 | 2019/05/29 | ||||||
| 药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn（注：已撤市） | 撤市原因：1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised. |